Source: Eur Respir Monogr 2011; 53: 1-10
Disease area: Respiratory critical care, Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
H.D. Aya B, J. Rello. Aetiopathogenesis of VAP revisited. Eur Respir Monogr 2011; 53: 1-10

Member's Comments

No comment yet.

Related content which might interest you: Community-acquired pneumonia through Enterobacteriaceae and Pseudomonas aeruginosa: diagnosis, incidence and predictors Source: Eur Respir J 2010; 35: 598-615 Year: 2010 MRSA as a cause of lung infection including airway infection, community-acquired pneumonia and hospital-acquired pneumonia Source: Eur Respir J 2009; 34: 1470-1476 Year: 2009 Ventilator-associated pneumonia due to colistin susceptible-only microorganisms Source: Eur Respir J 2007; 30: 307-313 Year: 2007 Early mortality in patients with community-acquired pneumonia: causes and risk factors Source: Eur Respir J 2008; 32: 733-739 Year: 2008 What is MRSA? Source: Eur Respir J 2009; 34: 1190-1196 Year: 2009 MRSA as a cause of community-acquired pneumonia Source: Eur Respir J 2009; 34: 1013-1014 Year: 2009 Diagnostic challenge in community-acquired pneumonia and hospital-acquired pneumonia: risk factors and diagnostic methods for methicillin resistant Staphylococcus aureus Source: Annual Congress 2006 - Methicillin resistant Staphylococcus aureus (MRSA): a real hospital-based pathogen? Year: 2006 Carbapenems for the treatment of immunocompetent adult patients with nosocomial pneumonia Source: Eur Respir J 2007; 29: 548-560 Year: 2007 Bacterial community-acquired pneumonia Source: Eur Respir Monogr 2014; 66: 98-111 Year: 2014 Enterobacteriaceae and Pseudomonas aeruginosa in community-acquired pneumonia: the reality after a decade of uncertainty? Source: Eur Respir J 2010; 35: 473-474 Year: 2010 The lung bacterial microbiome in community-acquired and nosocomial pneumonia Source: Eur Respir Monogr 2019; 83: 188-194 Year: 2019 Hospital-acquired and ventilator-associated pneumonia Source: ERS Courses: Paediatric respiratory infections Year: 2019 Community-acquired pneumonia due to multidrug and non-multidrug resistant pseudomonas aeruginosa Source: International Congress 2016 – Community-acquired pneumonia: from prevention to treatment Year: 2016 Community-acquired pneumonia in Europe: causative pathogens and resistance patterns Source: Eur Respir J 2002; 20: 20S-27S Year: 2002 New antibiotics for VAP Source: Eur Respir Mon 2011; 53: 48-53 Year: 2011 Impact of aspiration pneumonia in community-acquired pneumonia and healthcare-associated pneumonia Source: Annual Congress 2012 - CT findings: educational posters Year: 2012 Epidemiology of community-acquired pneumonia and nosocomial pneumonia Source: Annual Congress 2006 - PG1 - Respiratory infections: pneumonia/antibiotic resistance and clinical outcome of lower respiratory tract infections Year: 2006 Multidrug-resistant bacteria in community-acquired pneumonia Source: International Congress 2017 – PG17 Infectious disease challenges in community-acquired pneumonia and tuberculosis: improving your clinical practice Year: 2017 VAP: approach to therapy Source: Eur Respir Mon 2011; 53: 36-47 Year: 2011 Impact of methicillin resistance on mortality in Staphylococcus aureus VAP: a systematic review Source: Eur Respir J 2008; 31: 625-632 Year: 2008